Great Work Promoting Eli Lilly to a 22% Rise in 2015
As a leading believer in the future of the pharmaceutical business, Eli Lilly & Co. (LLY), I want to take this first week of the new year to look back on 2015 and celebrate all those who worked to increase its stock value by 22%.Shareholders whose investment gained value and Lilly employees who worked hard, kept their jobs, and are looking forward to future raises should be thanked for their role in building the company. The top businessmen, who are notoriously overlooked by non-Objectivists, are some of the biggest, power players and deserve all of our thanks for their productiveness and, thus, moral role as well.
The scientists, bio-technology inventors, and technicians must not be left out of our recognition. This includes the new innovators in theoretical science, too. In my blog, American Galileo, I introduced a lot of new scientific philosophy that can be found in the January 2015 blogs. I hope that my contributions will be adopted by more and more Eli Lilly innovators and spur the production of future medicines and other products.
Finally, I want to direct credit at myself for the non-scientific posts (such as the political blogs) that I laboriously prepared for and engaged in the blogosphere with. While I did not receive a salary, (unless one can count a 22% rise in my stock value--not including the dividend), my mind received the best fuel I could hope for--brand name Zyprexa. I find it odd whenever I come across the argument that a company is charging too much for a life-saving medicine. I paid full price at the local pharmacy for brand name Zyprexa for five or six years. I began my Eli Lilly promotion campaign while I was still paying over $10,000.00 per year. For a pizza delivery driver with minor mental health issues, that was no small sum. Then I found a way to satisfy the company enough to be worthy of their generous assistance. I can't imagine how much time I have put into this third job of mine: from the books I read, to the Objectivist CDs I listen to in my car, to Republican Talk Radio, to surfing the Internet to find everything that affects Eli Lilly, to getting an idea for a blog, to finding time to write it. That's the price one pays; and I love it! Let's beat 22% in 2016.
Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)
No comments:
Post a Comment